Di Giorgio Audrey, Tran Thi Phuong Anh, Duca Maria
University of Nice Sophia Antipolis, Institute of Chemistry of Nice UMR7272 CNRS, Faculté des Sciences, Parc Valrose, 06100 Nice, France.
Future Med Chem. 2016 May;8(7):803-16. doi: 10.4155/fmc-2016-0018. Epub 2016 May 5.
miRNAs are a recently discovered class of small noncoding RNAs implicated in the regulation of gene expression. The deregulation of miRNAs levels has been linked to the development of various cancers where oncogenic miRNAs are overexpressed and tumor suppressor miRNAs are underexpressed. Here we report the three main strategies developed in order to discover small-molecule drugs able to selectively interfere with oncogenic miRNAs: the high throughput screening of large libraries of compounds, the focused screening of small libraries of molecules that are known to be able to interact with RNA thus being supposed modulators of miRNAs pathway and the design of small molecules based on the secondary structure of targeted RNA and/or three-dimensional structure of enzymes involved in miRNAs pathway.
微小RNA(miRNAs)是最近发现的一类小的非编码RNA,参与基因表达调控。miRNAs水平失调与多种癌症的发生发展有关,在这些癌症中,致癌性miRNAs过表达,而肿瘤抑制性miRNAs表达不足。在此,我们报告为发现能够选择性干扰致癌性miRNAs的小分子药物而开发的三种主要策略:对大型化合物文库进行高通量筛选;对已知能够与RNA相互作用从而被认为是miRNAs通路调节剂的小分子文库进行聚焦筛选;以及基于靶向RNA的二级结构和/或参与miRNAs通路的酶的三维结构设计小分子。